DE3684903D1 - Zwitterion-bicyclische verbindungen, deren salze, solvate, hydrate und ester. - Google Patents

Zwitterion-bicyclische verbindungen, deren salze, solvate, hydrate und ester.

Info

Publication number
DE3684903D1
DE3684903D1 DE8686904707T DE3684903T DE3684903D1 DE 3684903 D1 DE3684903 D1 DE 3684903D1 DE 8686904707 T DE8686904707 T DE 8686904707T DE 3684903 T DE3684903 T DE 3684903T DE 3684903 D1 DE3684903 D1 DE 3684903D1
Authority
DE
Germany
Prior art keywords
esters
zwitterion
solvates
hydrates
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686904707T
Other languages
English (en)
Inventor
David John Blythin
Ho-Jane Shue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DE3684903D1 publication Critical patent/DE3684903D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Professional, Industrial, Or Sporting Protective Garments (AREA)
  • Outer Garments And Coats (AREA)
DE8686904707T 1985-07-29 1986-07-25 Zwitterion-bicyclische verbindungen, deren salze, solvate, hydrate und ester. Expired - Fee Related DE3684903D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/760,196 US4684727A (en) 1985-07-29 1985-07-29 Zwitterionic 1,8-naphthyridine and pyrazino[2,3-b]pyridine containing compounds useful as anti-allergic, anti-inflammatory and cycloprotective agents
PCT/US1986/001518 WO1987000752A2 (en) 1985-07-29 1986-07-25 Zwitterionic bicyclic compounds and their salts, solvates, hydrates and esters

Publications (1)

Publication Number Publication Date
DE3684903D1 true DE3684903D1 (de) 1992-05-21

Family

ID=25058394

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686904707T Expired - Fee Related DE3684903D1 (de) 1985-07-29 1986-07-25 Zwitterion-bicyclische verbindungen, deren salze, solvate, hydrate und ester.

Country Status (23)

Country Link
US (4) US4684727A (de)
EP (1) EP0232328B1 (de)
JP (1) JPH0794455B2 (de)
KR (1) KR900003490B1 (de)
AT (1) ATE74756T1 (de)
AU (1) AU597587B2 (de)
CA (1) CA1263654A (de)
CZ (1) CZ413991A3 (de)
DE (1) DE3684903D1 (de)
DK (1) DK157787D0 (de)
FI (1) FI871345A (de)
HU (1) HU201550B (de)
IE (1) IE59298B1 (de)
IL (1) IL79556A (de)
MX (1) MX9203320A (de)
MY (1) MY101970A (de)
NO (1) NO166862C (de)
NZ (1) NZ217016A (de)
OA (1) OA08501A (de)
PH (1) PH23887A (de)
PT (1) PT83080B (de)
WO (1) WO1987000752A2 (de)
ZA (1) ZA865631B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684727A (en) * 1985-07-29 1987-08-04 Schering Corporation Zwitterionic 1,8-naphthyridine and pyrazino[2,3-b]pyridine containing compounds useful as anti-allergic, anti-inflammatory and cycloprotective agents
US5037826A (en) * 1986-10-15 1991-08-06 Schering Corporation 1-substituted naphthyridine and pyridopyrazine derivatives
US5045542A (en) * 1986-10-20 1991-09-03 Schering Corporation Immune suppression method employing aryl-substituted naphthyridine and pyridopyrazine derivatives
US5350755A (en) * 1986-12-05 1994-09-27 Schering Corporation Compounds and methods for treating hyperproliferative skin disease
CA1309658C (en) * 1986-12-05 1992-11-03 David J. Blythin Pharmaceutical compositions for treatment of hyperproliferate skin disease
JPH07116187B2 (ja) * 1987-07-22 1995-12-13 シェリング・コーポレーション 二環式化合物、それらを薬剤として使用すること、それらの製法、およびそれらの製造に有用な中間体
US4897487A (en) * 1988-04-06 1990-01-30 Schering Corporation Process for preparing intermediates for pharmaceutically useful bicyclic compounds
US5079360A (en) * 1988-04-06 1992-01-07 Schering Corporation Processes for preparing bicyclic compounds and intermediates thereof
US5180823A (en) * 1988-04-06 1993-01-19 Schering Corporation Processes for preparing bicyclic compounds
US5341575A (en) * 1989-11-01 1994-08-30 Chisum Finis L Apparatus to gather, display, and/or print vehicle chassis measurement data for accurate repair of collision damaged vehicles
CA2091172C (en) * 1990-09-07 1997-05-20 Adriano Afonso Antiviral compounds and antihypertensive compounds
US5175151A (en) * 1990-09-07 1992-12-29 Schering Corporation Antiviral compounds and antihypertensive compounds
US5760034A (en) * 1990-11-30 1998-06-02 Schering Corporation Heterocyclic substituted naphthyridinones and methods and compositions employing them
GB9026389D0 (en) * 1990-12-05 1991-01-23 Merck Sharp & Dohme Therapeutic agents
US5179093A (en) * 1991-05-10 1993-01-12 Schering Corporation Quinoline-diones
JP2683783B2 (ja) * 1992-07-10 1997-12-03 雪印乳業株式会社 シェーグレン症候群治療剤
US7083777B1 (en) * 1999-04-02 2006-08-01 The Brigham And Women's Hospital, Inc. Immunomodulating polymers
SV2003000753A (es) 2000-12-05 2003-06-16 Brigham & Womens Hospital Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
WO2004089407A2 (en) * 2003-03-31 2004-10-21 The Brigham And Women's Hospital, Inc. Zwitterionic immunomodulators for the treatment of asthma and allergy
US8206726B2 (en) 2006-02-06 2012-06-26 The Brigham And Women's Hospital, Inc. Zwitterionic polysaccharides for promotion of immune system maturation and health
US9539281B2 (en) 2011-07-12 2017-01-10 The Brigham And Women's Hospital, Inc. Lipid-containing PSA compositions, methods of isolation and methods of use thereof
WO2017031431A1 (en) 2015-08-19 2017-02-23 President And Fellows Of Harvard College Lipidated psa compositions and methods
US11491181B2 (en) 2016-07-15 2022-11-08 President And Fellows Of Harvard College Glycolipid compositions and methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264602A (en) * 1975-08-15 1981-04-28 Sandoz, Inc. 4-Hydroxy-3-nitro-pyrido[2,3-B]pyridine-2(1H)-ones
FR2469962A1 (fr) * 1979-11-21 1981-05-29 Vallourec Procede et dispositif pour la fabrication d'un tube d'acier sans soudure par laminage a chaud sur mandrin
EP0092786B1 (de) * 1982-04-26 1987-01-07 Schering Corporation 1,8-Naphthyridine- und 1,5,8-Azanaphthyridine-Derivate
US4452800A (en) * 1982-04-26 1984-06-05 Schering Corporation Salts of 3(n-butyl)-4-hydroxy-1-phenyl-1,8-naphthyridine-2(1H)-one and their use in treating chronic obstructive lung diseases
US4551463A (en) * 1982-11-03 1985-11-05 Schering Corporation Composition containing 1-phenyl-1,8-naphthridin-2(1H)-ones and a non-steroidal anti-inflammatory drug
US4628055A (en) * 1982-11-03 1986-12-09 Schering Corporation Method for treating allergic reactions and compositions therefore
US4684727A (en) * 1985-07-29 1987-08-04 Schering Corporation Zwitterionic 1,8-naphthyridine and pyrazino[2,3-b]pyridine containing compounds useful as anti-allergic, anti-inflammatory and cycloprotective agents

Also Published As

Publication number Publication date
KR870700352A (ko) 1987-12-28
US4684727A (en) 1987-08-04
HU201550B (en) 1990-11-28
US4902693A (en) 1990-02-20
EP0232328B1 (de) 1992-04-15
IE861997L (en) 1987-01-29
KR900003490B1 (ko) 1990-05-21
WO1987000752A3 (en) 1987-05-21
MY101970A (en) 1992-02-29
NZ217016A (en) 1989-11-28
NO871311L (no) 1987-03-27
NO871311D0 (no) 1987-03-27
MX9203320A (es) 1992-07-01
FI871345A0 (fi) 1987-03-27
IE59298B1 (en) 1994-02-09
ZA865631B (en) 1987-03-25
JPH0794455B2 (ja) 1995-10-11
US4782067A (en) 1988-11-01
DK157787A (da) 1987-03-27
NO166862C (no) 1991-09-11
PT83080A (en) 1986-08-01
AU597587B2 (en) 1990-06-07
WO1987000752A2 (en) 1987-02-12
JPS63500453A (ja) 1988-02-18
NO166862B (no) 1991-06-03
CZ413991A3 (en) 1993-01-13
US4794116A (en) 1988-12-27
PH23887A (en) 1989-12-18
FI871345A (fi) 1987-03-27
ATE74756T1 (de) 1992-05-15
IL79556A (en) 1995-05-26
AU6147986A (en) 1987-03-05
PT83080B (pt) 1989-01-30
CA1263654A (en) 1989-12-05
HUT42481A (en) 1987-07-28
DK157787D0 (da) 1987-03-27
EP0232328A1 (de) 1987-08-19
OA08501A (en) 1988-07-29

Similar Documents

Publication Publication Date Title
DE3684903D1 (de) Zwitterion-bicyclische verbindungen, deren salze, solvate, hydrate und ester.
FI863652A0 (fi) 7-isopropoxiisflavoninklusionskomplex bildat med cyklodextrin och ett foerfarande foer dess framstaellning.
HUT46683A (en) Process for producing 1-/4-hydroxy-3,5-di/terc-butyl-benzoyi/-homopiperazin and derivatives and pharmaceutical compositions containing them
ZA886097B (en) Pharmaceutical composition for the treatment of psoriasis
IL58103A0 (en) Sila-substituted 1,4-dihydropyridine derivatives their production and pharmaceutical compositions containing them
IT1216772B (it) Derivati di indolo ,procedimento per prepararli e composizioni farmaceutiche che li contengono per il trattamento di emicrania
SE8302979L (sv) Piperazinderivat, deras framstellning och farmaceutiska kompositioner innehallande dessa
SE8306225D0 (sv) 2-piperazinyl-quinazoline derivatives, their production and pharmaceutical compositions containing them
DE2963010D1 (en) 3-chloro-6-hydroxy-5-methylbenzoic acid derivatives, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds for promoting growth in certain animals and their manufacture
HUT61769A (en) Process for producing new spirocyclopropyl-cephalosporin derivatives and pharmaceutical compositions containing them
IT1201963B (it) Derivati delle rifamicine e procedimento per la loro preparazione
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
YU108291A (sh) Postupak za dobijanje farmaceutskih kombinacijskih preparata koji sadrže cefalosporinske i ksantinske derivate
DK22983A (da) Fremgangsmaade til fremstilling af penicillinderivater
IT1249041B (it) Derivati della diosmina, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ITMI921125A1 (it) Procedimento per la preparazione di derivati beta-lattamici alogenati
DK239084A (da) 2-alkylthio-1-aminoalkyl-2-pyrrolin-3-carbonitriler
IT1254742B (it) Impiego della beta-endorfina quale farmaco immunosoppressore nei trapianti d'organo

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee